Distinguishing the progression of an endometrioma: Benign or malignant?

Author
TAKMAZ, Özgüç
Ozaltin, Selin
GÖRGEN, Hüsnü
GÜNGÖR, Mete
Keskin, Gulsah
Demiral, Irem
Yavuz, Ekrem
Buyru, Faruk
Ozsurmeli, Mehmet
Onder, Semen
BAŞTU, Ercan
Metadata
Show full item record
Abstract
Objective: To elucidate the immunohistochemical (IHC) differences of endometrioma tissues that may have the potential to progress to ovarian clear cell carcinoma (OCCC) by using KRAS, HNF1 beta, PIK3CA, PPP2R1A, and ARID1A as biomarkers.
URI
http://hdl.handle.net/20.500.12627/129391
https://doi.org/10.1016/j.ejogrb.2018.09.026
Collections